CEBPD-induced SOD1 expression mediates cisplatin resistance in human bladder urothelial carcinoma cell line NTUB1
碩士 === 高雄醫學大學 === 生物化學研究所 === 97 === 英文摘要 Cisplatin (cis-diaminedichloroplatinum;CDDP), a platinum- based anticancer drug, is one of the most effective chemo- therapeutic agents. Its configuration includes two amines, two chlorines, and the center of platinum. The cytotoxic effect of cisplatin is ma...
Main Authors: | Yan-Liang Lai, 賴彥良 |
---|---|
Other Authors: | A-Mei Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/15514282042312948774 |
Similar Items
-
Molecular mechanism of CEBPD-mediated gemcitabine response in human bladder urothelial carcinoma cell line NTUB1
by: Shin-Zao Toh, et al.
Published: (2008) -
The role of PTEN in CEBPD-mediated cisplatin response in human urothelial carcinoma
by: Huei-Ting Hu, et al.
Published: (2012) -
Molecular mechanism of gemcitabine-induced Cyclin D1 down-regulation in human urothelial carcinoma NTUB1
by: Wei-Chi Hsu, et al.
Published: (2012) -
The Role of MiR-193b-3p in CEBPD-Mediated Cisplatin Response in Human Urothelial Carcinoma
by: Siao-Ren Lin, et al.
Published: (2013) -
Characterization of Cebpd in response to cisplatin in mouse embryonic fibroblasts
by: Wa-Ju Shan, et al.
Published: (2007)